Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Free PMC article
Full text links

Actions

Share

.2008 Dec;5(4):383-9.
doi: 10.1093/ecam/nem085. Epub 2007 Sep 13.

Blinding techniques in randomized controlled trials of laser therapy: an overview and possible solution

Affiliations

Blinding techniques in randomized controlled trials of laser therapy: an overview and possible solution

Ian Relf et al. Evid Based Complement Alternat Med.2008 Dec.

Abstract

Low-level laser therapy has evidence accumulating about its effectiveness in a variety of medical conditions. We reviewed 51 double blind randomized controlled trials (RCTs) of laser treatment. Analysis revealed 58% of trials showed benefit of laser over placebo. However, less than 5% of the trials had addressed beam disguise or allocation concealment in the laser machines used. Many of the trials used blinding methods that rely on staff cooperation and are therefore open to interference or bias. This indicates significant deficiencies in laser trial methodology. We report the development and preliminary testing of a novel laser machine that can blind both patient and operator to treatment allocation without staff participation. The new laser machine combines sealed preset and non-bypassable randomization codes, decoy lights and sound, and a conical perspex tip to overcome laser diode glow detection.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) DBL Laser machine in operation for a placebo treatment. Demonstration of laser probe applied to left hand whilst machine is activated. The dummy red light is visible on the skin and is shining out of the end of the probe. The probe is activated by pressing the tiny button visible on the central part of the probe. In this instance, the machine is in full operation, however the invisible infrared laser is switched off as would be the situation for a placebo treatment. The machine activation light on the laser front panel can be seen at the top left of the photograph. Aspect; DBL Laser machine is in the background sitting on carry case. (B) Front panel DBL laser machine. Four-digit patient entry code switch sited in upper right of panel. Indicator lights for machine operation in upper left. Laser probe (white) cord inserted into bottom right panel. Timer switch - central. Manual key lock and power on/off toggle in lower left of panel. Aspect; DBL Laser machine sitting on steel carry case.
Figure 2.
Figure 2.
DBL Laser machine specifications.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Pirotta MV, Cohen MM, Kotsirilos V, Farish SJ. Complementary therapies: have they become accepted in general practice? Med J Aust. 2000;172:105–9. - PubMed
    1. Schlager A, Offer T, Baldissera I. Laser stimulation of acupuncture point P6 reduces postoperative vomiting in children undergoing strabismus surgery. Br J Anaesth. 1998;81:529–32. - PubMed
    1. Bjordal JM, Couppe C, Chow RT, Tuner J, Ljunggren EA. A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders. Aust J Physiother. 2003;49:107–16. - PubMed
    1. Hopkins JT MT, Seegmiller JG, Baxter GD. Low-level laser therapy facilitates superficial wound healing in triple blind, sham-controlled study. J Athl Train. 2004;39:223–9. - PMC - PubMed
    1. Radmayr C, Schlager A, Studen M, Bartsch G. Prospective randomized trial using laser acupuncture versus desmopressin in the treatment of nocturnal enuresis. Eur Urol. 2001;40:201–05. - PubMed

Related information

LinkOut - more resources

Full text links
Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp